The revised Common Rule no longer requires IRBs to conduct review of grants to ensure they are consistent with an IRB application. In light of this change, the IRB offices will no longer conduct review of any grant or clinical trial agreement associated with an IRB application. Instead, the PI for the grant will be responsible for confirming that the human subjects research activities described in the grant are covered by an approved or exempt IRB application(s). This FAQ explains how the new process will be implemented as well as future funding-related changes to ARROW.
The flexibility in the revised Common Rule is being leveraged by OVCRGE leadership to replace what has become an at times overly complex funding review process. Principal investigators (PIs) have always been responsible for ensuring that they have obtained the required approvals for human subjects research activities described in their grants. The new process just removes the extra layer of IRB review, which will simplify and help reduce the time applications spend in IRB administrative review.
ARROW will be updated August 3rd to include the changes necessary to the forms and letters for implementation of the streamlined congruency process.
ARROW and WISPR will include the following tools and reminders to assist researchers in ensuring that the research described in their IRB application(s) is consistent with the research described in their grant(s) and that they have obtained the appropriate approvals for human subjects research activities described in their funding sources:
The IRB will review funding information only to ascertain the type of funding that is listed (e.g., federal vs. not, funding agency if federal). The grant application will no longer be uploaded in the IRB application and hence will not be reviewed by IRB staff. This includes applications for review of training, core, or umbrella grants, for which the study team will need to provide sufficient detail in the application form to enable appropriate IRB review.
Yes, funding sources still need to be listed in the IRB application to ensure both the PI and the institution are in compliance with applicable regulations.
Yes and yes. No changes are being made to how many funding sources can be listed in a single IRB application nor to how many studies a grant may support.
Yes. A PDA can still be submitted to allow release of grants funds for study activities NOT involving human subjects research. As previously, study teams are encouraged to consult with their program officer or grants management specialist to confirm that a PDA approval will be acceptable to the funding agency.
Several changes to funding-related review processes are being planned and are targeted for implementation in fall 2019, including:
If you have questions about the new process or upcoming changes to funding-related review processes, please contact Lynn Haynes (email@example.com).